Patents by Inventor Jiyong SHIM

Jiyong SHIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for preventing hair loss or promoting hair growth
    Patent number: 11154566
    Abstract: The present invention is about composition for preventing hair loss or promoting hair growth comprising indirubin derivatives; and one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin; as an active ingredient. In addition, one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin of the present invention is a natural-derived composition with little toxicity to cells. Indirubin derivatives are stable compounds that have been found to have little toxicity to the human body, and therefore, when used in a mixture thereof, there are advantages in that they do not exhibit adverse effects on the human body, unlike conventional steroid drugs.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: October 26, 2021
    Assignee: CK BIOTECH
    Inventors: Kang-Yell Choi, Jiyong Shim, Yeong Chan Ryu, Jiyeon Park
  • COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH
    Publication number: 20200179425
    Abstract: The present invention is about composition for preventing hair loss or promoting hair growth comprising indirubin derivatives; and one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin; as an active ingredient. In addition, one or more selected from the group consisting of Euodia daniellii extract, Persicaria hydropiper extract, Hovenia dulcis extract, methyl vanillate, hesperidin and quercitrin of the present invention is a natural-derived composition with little toxicity to cells. Indirubin derivatives are stable compounds that have been found to have little toxicity to the human body, and therefore, when used in a mixture thereof, there are advantages in that they do not exhibit adverse effects on the human body, unlike conventional steroid drugs.
    Type: Application
    Filed: July 31, 2018
    Publication date: June 11, 2020
    Applicant: CK BIOTECH
    Inventors: Kang-Yell CHOI, Jiyong SHIM, Yeong Chan RYU, Jiyeon PARK